Neuroleptic malignant syndrome and clozapine monotherapy

Australian and New Zealand Journal of Psychiatry

Volumn 30, Issue 5, 1996, Pages 692-693

  Chatterton, Ray ^a,b   Cardy, Susette ^a   Schramm, T Mark ^a  

^a WOLSTON PARK HOSPITAL   (Australia)

^b Clozaril Patient Monitoring System   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CLOZAPINE; DIAZEPAM; DROPERIDOL;

ABDOMINAL PAIN; ADULT; AGITATION; ARTICLE; CASE REPORT; CONFUSION; DIAPHORESIS; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; NAUSEA; NEUROLEPTIC MALIGNANT SYNDROME; PALLOR; POLYDIPSIA; POLYURIA; RIGIDITY; SYMPTOMATOLOGY; THORAX PAIN; VERTIGO;

EID: 0029851333     PISSN: 00048674     EISSN: None     Source Type: Journal    
DOI: 10.3109/00048679609062668     Document Type: Article

References (3)

1. Thornberg S, Ereshefsky L. Neuroleptic malignant syndrome associated with clozapine monotherapy. Pharmacotherapy 1993, 13:510-514.
2. Reddig S, Minnema A, Tandon R. Neuroleptic malignant syndrome and clozapine. Annals of Clinical Psychiatry 1993; 5:25-27.
3. Weller M, Kornhuber J. Does clozapine cause neuroleptic malignant syndrome? Journal of Clinical Psychiatry 1993; 54:70-71.